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HIV and severe bacterial infections in Africa
R. Heyderman
Malawi-Liverpool-Wellcome Trust, Chichiri,
Blantyre, Malawi
Severe bacterial infection (SBI) is one of the principal deter-
minants of the morbidity and mortality associated with advanced
HIV infection, especially in sub-Saharan Africa (SSA). Prior to the
introduction of antiretroviral therapy (ART), large African hospi-
tals have reported a 70% adult in-hospital HIV prevalence and a
38% case fatality among individuals with culture conﬁrmed SBI. A
recent meta-analysis of BSI in Africa found that the most frequent
bacterial causes of adult BSI in SSA were Nontyphoidal Salmonellae
(NTS) and Streptococcus pneumoniae, and with the exception of S.
Typhi bacteremia, HIV co-infection was a prominent risk factor for
any cause of BSI. Over the last 10 years, there has been rapid roll-out
of ART and cotrimoxazole prophylactic therapy (CPT) in many high
HIV prevalence African countries. A fall in HIV associated BSI has
been described in industrial settings, but whether and how BSI has
changed in the era of rapid ART and CPT roll-out in African adults
has not been well described. In this review, trends in adult SBI in
Malawi in the context of ART roll-outwill be described, the basis for
the emergence and decline of invasive non-typhoidal salmonella
explored, and the potential for chronically HIV-infected adults sta-
ble on HIV to act as a reservoir for vaccine escape & emergence of
antimicrobial resistance discussed.
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Should HIV and tuberculosis services be
integrated in settings with high TB/HIV
co-infection?
B. Harley
Cape Town Municipality, Cape Town, South Africa
Integration of TB and HIV services in settings with high co-
infection, has received a lot of attention yet remains a challenge.
Direction fromWHOcame in2001 following theﬁrstmeetingof the
global working group on TB/HIV; the terminology at the time was
“programme interaction” and “collaboration”, which has shifted to
“integration”, but what remains is lack of clarity as to exactly what
integration means, how to achieve it and the beneﬁts and chal-
lenges associatedwith it. Data frommany settings shows very high
co-infection rates: this overlapping epidemiology and the goal of
providing client-centred care are at the core of the push to inte-
grate services. It has been easier to achieve integration of TB and
HIV services at single, well deﬁned points within the traditional,
vertical, TB and HIV services and less so for services which are
provided over a length of time. There is scanty and conﬂicting evi-
dence that integration per se leads to better treatment outcomes
or is more cost effective. Other challenges in making integration
a reality include infection control and buy-in and integration at
all levels of funding, service delivery and programme support, as
well as the lag in development and solidly embedding changes in
the system such as in policy, training and monitoring and eval-
uation (including stationery, manual and electronic registers and
audit tools). Implementing integrated TB and HIV services has also
often been tackled in conjunction with other changes in the sys-
tem, such as decentralisation or the addition of new services (HIV
related) with limited or no extra resources being provided, includ-
ing for the change management process. There are also broader
integration issues, such aswith sexual and reproductive health and
substance abuse, andwith the growing cohort of ageing ART clients
at increased risk of cardiovascular disease even with viral suppres-
sion, overlapping epidemiology of hypertension and diabetes with
HIV is set to increase. In conclusion, there is a push to integrate TB
and HIV services, but much remains for this integration to be opti-
mally implemented in diverse settings and to ﬁnd its place in the
landscape of broader health system changes.
http://dx.doi.org/10.1016/j.ijid.2014.03.509
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An outbreak of New Delhi
Metallo--Lactamase-1 producing
enterobacteriaceae: A case-control study
P. de Jager1,∗, J. Thomas2, T. Chirwa1, S. Naidoo1
1 University of the Witwatersrand, Johannesburg,
South Africa
2 National Institute for Communicable Diseases,
Johannesburg, South Africa
Background: NDM-1, ﬁrst discovered in 2008, is highly trans-
ferable between various Enterobacteriaceae and confers high-level
antimicrobial resistance to multiple classes of commonly used
antibiotics. The ﬁrst South African NDM-1 case was reported in
September 2011. We describe a case-control study of an NDM-1
producing Enterobacteriaceae outbreak which occurred in a 322-
bed South African hospital and identify risk factors associated with
invasive disease and mortality.
Methods & Materials: All reported NDM-1 positive patients
(n =97) identiﬁed between 1 June 2011 and 31 October 2012 were
reviewed. The inclusion criteria was all patients admitted during
the study period in whom NDM-1 producing Enterobacteriaceae
isolates causing invasive disease were identiﬁed at least 48hours
after admission (n=41). Controls (n =78) were randomly selected
and matched for age, sex, date of hospital admission, and intensive
care unit (ICU) admission. Bivariate conditional logistic regression
was used to identify risk factors for NDM-1 invasive disease as
well as death. A forward multivariate conditional logistic regres-
sionmodelwas utilised to identify signiﬁcant predictors forNDM-1
invasive disease and death.
